Author:
Nabha Linda,Duong Lan,Timpone Joseph
Publisher
Springer Science and Business Media LLC
Reference88 articles.
1. WHO. HIV/AIDS: fact sheet no. 360; 2012. http://www.who.int/mediacentre/factsheets/fs360/en/index.html (cited 9 Jan 2013).
2. Cysique LA, Bain MP, Brew BJ, Murray JM. The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future. Sex Health. 2011;8(4):541–50.
3. Letendre S, McClernon D, Ellis R, Munoz-Moreno J, Way L, Franklin D, Heaton R, Grant I. Persistent HIV in the central nervous system during treatment is associated with worse antiretroviral therapy penetration and cognitive impairment. Presented at: 16th Conference on Retroviruses and Opportunistic Infections; 2009 Feb 8–11; Montréal, Canada.
4. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3–16.
5. Canestri A, Lescure FX, Jaureguiberry S, Moulignier A, Amiel C, Marcelin AG, et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis. 2010;50(5):773–8.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献